...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Plasticity of GABAergic Mechanisms Within the Nucleus of the Solitary Tract in Hypertension
【24h】

Plasticity of GABAergic Mechanisms Within the Nucleus of the Solitary Tract in Hypertension

机译:高血压孤立性道核内GABA能机制的可塑性

获取原文
           

摘要

Adaptive changes have long been recognized to occur in the heart and vasculature in response to chronic hypertension. What might be less well-appreciated is the fact that chronically increased blood pressure is also associated with adaptive changes in neurons within the central nervous system (CNS). Changes in the properties of ligand-gated and voltage-gated channels have been described in a variety of neurons in a variety of central nuclei and in a variety of models of hypertension.Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in virtually every region in the adult brain. Microinjections of GABA and GABA receptor subtype-selective agonists and antagonists have been performed within various cardiovascular-related regions of the CNS. In every cardiovascular-related region of the CNS tested, activation of GABA receptors alters cardiovascular function. This is likely attributable to the ubiquitous role of GABA within the CNS. GABAergic inhibition can be mediated by activation of receptors located in presynaptic and postsynaptic loci. Two major subtypes of the GABA receptor exist: the GABAA receptor is a pentameric, chloride ionophore that primarily mediates postsynaptic inhibition,1 whereas the GABAB receptor is a G-protein-coupled receptor that can induce reductions in calcium conductance to mediate presynaptic inhibition and increases in potassium conductance to mediate postsynaptic inhibition.2GABAergic inhibition of central neurons can result in pressor or depressor responses depending on the central site being examined. Pressor responses are often assumed to be the result of GABAergic inhibition of neurons that reduce sympathetic discharge. Depending on the specific area being studied, GABA injections into the CNS can also alter vagal cardiac function and levels of vasoactive hormones such as vasopressin and angiotensin, in addition to changes in sympathetic outflow.3,4In addition to microinjection studies, in vivo and in vitro electrophysiological analyses of functionally identified neurons in cardiovascular-related CNS …
机译:长期以来,人们已经认识到适应性变化发生在对慢性高血压的反应中的心脏和脉管系统中。人们可能不太了解的事实是,慢性血压升高也与中枢神经系统(CNS)中神经元的适应性变化有关。配体门控和电压门控通道特性的变化已在各种中央核的各种神经元和各种高血压模型中得到了描述.γ-氨基丁酸(GABA)是实际上抑制神经系统的主要递质成人大脑的每个区域。在中枢神经系统的各种心血管相关区域内已进行了GABA和GABA受体亚型选择性激动剂和拮抗剂的显微注射。在受测中枢神经系统的每个与心血管相关的区域中,GABA受体的激活都会改变心血管功能。这可能归因于GABA在中枢神经系统中的普遍作用。可以通过激活位于突触前和突触后基因座的受体来介导GABA能抑制。 GABA受体有两种主要的亚型:GABAA受体是一种五聚体氯化物离子载体,主要介导突触后抑制,1而GABAB受体是一种G蛋白偶联受体,可以诱导钙电导降低,从而介导突触前抑制并增加。 2GABA能抑制中枢神经元可导致升压或降压反应,具体取决于所检查的中枢部位。通常认为升压反应是GABA能抑制神经元减少交感神经放电的结果。根据所研究的特定区域,除交感神经外流变化外,向中枢神经系统注射GABA还可以改变迷走性心脏功能和血管活性激素(如加压素和血管紧张素)的水平3,4。心血管相关中枢神经系统中功能识别神经元的体外电生理分析

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号